Bill Mohri

Founder and CEO @ SoluPet Supplements & SoluSci Health

📍 Toronto, Ontario, Canada🔄 Updated September 2026💼 6 investments📅 11 years investing🗓 Last invested Jan 2024
VC🌍 Canada
6
Total investments
0
Early stage
4
Mid stage
0
Late stage
11y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Aug 2018
Next Remedies (NR) has developed a scientifically proven, patent-pending, water-soluble formulation and its novel applications for halting the progression of neurodegenerative diseases through an affordable, direct-to-market business model. Our mission is to halt the progression of dementia in current sufferers AND to prevent the threat of dementia for the next generation.
Investor
Aug 2017
HydRx is a vertically-integrated manufacturer and distributor of cannabis and nutraceutical products.
Investor
Oct 2016
Cinnos is a purpose-driven company, filled with passionate people, dedicated to creating innovative solutions that make our world better. We believe, that the traditional model of building data centers is limiting and unsustainable, both environmentally and financially. Cinnos addresses this, through combining the best ideas of design, reliability and efficiency into prefabricated, scalable, and operationally optimized modular products & solutions. Economic, societal, and environmental concerns are at the heart of everything we do, from R&D to operations. We are dedicated to continually bringing innovation-driven sustainable practices to the computing infrastructure industry. Cinnos has introduced the world’s first mass-customizable, plug-and-play datacentre appliance line, the Smart MCX™ system. The Smart MCX™ allows immediate deployment of computing infrastructures. This is in stark contrast to the traditional way of establishing datacentres, which entails substantial on-site construction. Thus, it accelerates time-to-market, and thus revenues, for its users, enabling drastically higher ROI than legacy technologies. The product line is designed in modules, which can be combined to customize your capacity needs. This past year we helped numerous companies deploy datacentre solutions resulting in 90% deferred capital costs, 43% reduction in their cost of deployment, 12% increase in operational efficiency, and providing the shortest investment paybacks by enabling the assembly of a datacentre in just 1 week. In addition, Cinnos in collaboration with McMaster University, has established the Computing Infrastructure Research Centre (CIRC). This space is the first of its kind in Canada! Please feel free to visit our website - www.cinnos.com - to get an in-depth look at what Cinnos can do for you.
Investor
Aug 2015
Amgine is the parent company of HelloGbye, an industry-leader that uses patented AI-Assist technology to make the travel industry more efficient.
mid stageInternet
Experience · 10 entries
All (10)
Investments (6)
Founder (3)
2024
Founder and CEO at SoluSci Health
Nov 2024
Founder and CEO
Jan 2024
SoluPet is revolutionizing the pet sectors companion animal health category with its advanced supplement offering. SoluPet is a science and data driven company focused on transforming pet health care. SoluPet offers pet owners an effective option for treating debilitating pet conditions like Canine Cognitive Dysfunction.
early stagePet Services
Angel Investor
Jan 2024
Keiretsu Forum is a global investment community of accredited private equity investors, venture capitalists and corporate/institutional investors. Keiretsu Forum members invest in high-quality, diverse investment opportunities. The community is strengthened through its involvement in social and charitable activities. "Keiretsu"​ definition Keiretsu is a Japanese term describing a group of affiliated corporations with broad power and reach. Keiretsu Forum is described as a conglomeration of individuals or small companies that are organized around private equity funding for mutual benefit. Keiretsu Forum believes that through a holistic approach that includes interlocking relationships with partners and key resources, they can offer an association that produces the highest quality deal-flow and investment opportunities.
2018
Angel Investor
Aug 2018
Next Remedies (NR) has developed a scientifically proven, patent-pending, water-soluble formulation and its novel applications for halting the progression of neurodegenerative diseases through an affordable, direct-to-market business model. Our mission is to halt the progression of dementia in current sufferers AND to prevent the threat of dementia for the next generation.
2017
Investor
Aug 2017
HydRx is a vertically-integrated manufacturer and distributor of cannabis and nutraceutical products.
Show all 10 entries ↓
Investment activity
2015–2024 · 6 investments
2015120161201722018120241
Recent (last 2 years)Earlier